Preventing hydrolysis of AlN powders with organophosphate coating in aqueous media

The coating of aluminum nitride powder has a great importance industrially and environmentally. AlN can be rapidly hydrolyzed to aluminum hydroxide and ammonia in the atmosphere or water media. To prevent the hydrolysis of AlN, the inorganic or organic based coatings are used frequently. For the first time, this study describes the phosphate esters as organophosphate coating used for the inhibition of hydrolysis reaction of AlN in its water suspension. Phenyl phosphate showed the best inhibition against AlN hydrolysis with an easy application technique and at low concentration of 0.005 M. AlN coating efficiency was proved by spectroscopic and imaging methods. It was concluded that the coating acquired the protective properties of phenyl phosphate through its water repellence

Spectroscopic and electrochemical characterizations of copper complexes with thionine, azure C and azure A

Structures held together by secondary interactions such as intramolecular or intermolecular hydrogen bonding, electrostatic and π–π interaction without covalent bonds can exhibit new properties such as high orientation, optoelectronics, biocompatibility and reversibility (self-renewal). Recently, interest has been growing surrounding novel molecules fashioned through non-covalent interactions. These molecules have garnered attention due to their significant roles in both physical and chemical applications. However, the formation of complexes between cationic phenothiazine derivative dyes, commonly employed in electrochemical studies, and diverse metal groups presents a challenge. Therefore, the existing literature contains only a scant number of studies concerning the formation of phenothiazine complexes with metal salts. In this study, metal complexes of thionine, azure C and azure A with copper(II) chloride were prepared using two steps: dissolving and then slow evaporation of dyes-copper(II) chloride in acetonitrile. Besides the theoretical computations, thermal, spectral, electrochemical and fluorescence techniques were performed to determine the characteristics of the monoclinic crystals of Cu–dyes complexes. Cl− ion in the dyes and copper(II) chloride conjugated to form [CuCl3]−, then this anion electrostatically bound to cationic phenothiazine ring bond to be phenothiazine+[CuCl3]−. Cu–dye complexes showed interestingly high electron transportation. In addition, prepared Cu–dye complexes have a great potential to be used in optical and spectral applications with extraordinary behaviour of their spectral and fluorescence features

Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2

The scale of the COVID-19 pandemic forced urgent measures for the development of new therapeutics. One of these strategies is the use of convalescent plasma (CP) as a conventional source for passive immunity. Recently, there has been interest in CP-derived exosomes. In this report, we present a structural, biochemical, and biological characterization of our proprietary product, convalescent human immune plasma-derived exosome (ChipEXO), following the guidelines set forth by the Turkish Ministry of Health and the Turkish Red Crescent, the Good Manufacturing Practice, the International Society for Extracellular Vesicles, and the Gene Ontology Consortium. The data support the safety and efficacy of this product against SARS-CoV-2 infections in preclinical models

Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.

The scale of the COVID-19 pandemic forced urgent measures for the development of new therapeutics. One of these strategies is the use of convalescent plasma (CP) as a conventional source for passive immunity. Recently, there has been interest in CP-derived exosomes. In this report, we present a structural, biochemical, and biological characterization of our proprietary product, convalescent human immune plasma-derived exosome (ChipEXO), following the guidelines set forth by the Turkish Ministry of Health and the Turkish Red Crescent, the Good Manufacturing Practice, the International Society for Extracellular Vesicles, and the Gene Ontology Consortium. The data support the safety and efficacy of this product against SARS-CoV-2 infections in preclinical models

Vaccination status of COVID-19 patients followed up in the ICU in a country with heterologous vaccination policy: A multicenter national study in Turkey

Objective: Vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-2) prevents the development of serious diseases has been shown in many studies. However, the effect of vaccination on outcomes in COVID-19 patients requiring intensive care is not clear. Methods: This is a retrospective multicenter study conducted in 17 intensive care unit (ICU) in Turkey between January 1, 2021, and December 31, 2021. Patients aged 18 years and older who were diagnosed with COVID-19 and followed in ICU were included in the study. Patients who have never been vaccinated and patients who have been vaccinated with a single dose were considered unvaccinated. Logistic regression models were fit for the two outcomes (28-day mortality and in-hospital mortality). Results: A total of 2968 patients were included final analysis. The most of patients followed in the ICU during the study period were unvaccinated (58.5%). Vaccinated patients were older, had higher Charlson comorbidity index (CCI), and had higher APACHE-2 scores than unvaccinated patients. Risk for 28-day mortality and in-hospital mortality was similar in across the year both vaccinated and unvaccinated patients. However, risk for in-hospital mortality and 28-day mortality was higher in the unvaccinated patients in quarter 4 adjusted for gender and CCI (OR: 1.45, 95% CI: 1.06–1.99 and OR: 1.42, 95% CI: 1.03–1.96, respectively) compared to the vaccinated group. Conclusion: Despite effective vaccination, fully vaccinated patients may be admitted to ICU because of disease severity. Unvaccinated patients were younger and had fewer comorbid conditions. Unvaccinated patients have an increased risk of 28-day mortality when adjusted for gender and CCI

Latent Tuberculosis Infection Management in Solid Organ Transplantation Recipients: A National Snapshot

OBJECTIVE: Latent tuberculosis infection (LTBI) screening is strongly recommended in the pre-transplant evaluation of solid organ transplant (SOT) recipients, although it remains inadequate in many transplant centers. We decided to investigate pre-transplant TB risk assessment, LTBI treatment, and registry rates in Türkiye. MATERIAL AND METHODS: Adult SOT recipients who underwent tuberculin skin test (TST) and/or interferon-gamma release test (IGRA) from 14 centers between 2015 and 2019 were included in the study. An induration of ≥5 mm on TST and/or probable/positive IGRA (QuantiFERON-TB) was considered positive for LTBI. Demographic features, LTBI screening and treatment, and pre-/post-transplant TB history were recorded from the electronic database of transplantation units across the country and pooled at a single center for a unified database. RESULTS: TST and/or IGRA were performed in 766 (33.8%) of 2266 screened patients most of whom were kidney transplant recipients (n = 485, 63.4%). LTBI screening test was positive in 359 (46.9%) patients, and isoniazid was given to 203 (56.5%) patients. Of the patients treated for LTBI, 112 (55.2%) were registered in the national registry, and 82 (73.2%) completed the treatment. Tuberculosis developed in 6 (1.06%) of 563 patients who were not offered LTBI treatment. CONCLUSION: We determined that overall, only one-third of SOT recipients in our country were evaluated in terms of TB risk, only 1 of the 2 SOT recipients with LTBI received treatment, and half were registered. Therefore, we want to emphasize the critical importance of pre-transplant TB risk stratification and registration, guided by revised national guidelines